University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > SFGH PHP Grand Rounds > Vaccines Update > Slides
An Update on Clinical Trials of Preventive HIV Vaccines
Slide Presentation
June 6, 2007
Jonathan Fuchs, MD, MPH
Tom Kennedy

Click on slide thumbnails to view full-sized image.

Jonathan Fuchs' powerpoint slides
Tom Kennedy's powerpoint slides

Slide 1.

An Update on Clinical Trials of Preventive HIV Vaccines
Slide 1.

Overview
Slide 1.

11,000 New Infections a Day in 2006
Slide 1.

Why a Vaccine to Prevent HIV?
Slide 1.

How Long It Takes to Develop Effective Vaccines
Slide 1.

Reasons for Optimism
Slide 1.

The Goals of a Preventive HIV Vaccine
Slide 1.

Possible Mechanisms for Vaccine-Induced Protective Immunity
Slide 1.

The Level of HIV in the Blood Stream Predicts Subsequent Survival
Slide 1.

Can a Vaccine Reduce the Viral Set Point?
Slide 1.

Plasma VL and Risk of Transmission in an Untreated Ugandan Community Study
Slide 1.

Vaccine Approaches in Clinical Trials
Slide 1.

The Rise and Fall of Vaccine Approaches
Slide 1.

Clinical Trials of Preventive HIV Vaccines
Slide 1.

Safety Has Not Been the Problem
Slide 1.

Few Adverse Events Are Related To Vaccine
Slide 1.

Even When Related to Vaccine, Most Adverse Events Are Mild
Slide 1.

Immunogenicity Disappointing, Part 1: Subunit Vaccines
Slide 1.

Is This What We Will Have to Achieve?
Slide 1.

VAX003: gp120 B/E' in IDU in Thailand
Slide 1.

Immunogenicity Disappointing: Part 2 Canarypox
Slide 1.

But Not All Pox-Based Vaccines Are Alike
Slide 1.

Adenoviral Vectors
Slide 1.

SHIV Challenge of Ad5-SIV gag Immunized Rhesus Monkeys
Slide 1.

rAd5 Vector #1: MRKAd5 Trivalent Vaccine
Slide 1.

MRKAd5 Trivalent gag/pol/nef
Slide 1.

STEP Study Overview
Slide 1.

Cross-Clade Reactivities: Ad5-Gag B Immunized Volunteers Can Recognize Clade A and C Gag Antigens
Slide 1.

HVTN 503: Phambili
Slide 1.

Multi-Gene, Multi-Clade DNA and rAd5 VRC Vaccines
Slide 1.

Phase II Trials of VRC DNA/rAd5 Candidate HIV-1 Vaccine
Slide 1.

PAVE 100
Slide 1.

New Vaccine Vectors in Development
Slide 1.

Upcoming Trials in San Francisco: Fall 2007
Slide 1.

Requirements for Study Participation
Slide 1.

Vaccine-Induced Antibody Positivity
Slide 1.

HIV Western Blot
Slide 1.

Mean Rate of HIV Tests per 1000 Patient-Visits in Persons Aged 18 Years or Older (December 2003-December 2006), San Francisco Department of Public Health Medical Care System
Slide 1.

Summary
Slide 1.

Acknowledgements
Slide 1.

Some Helpful Internet Resources
Slide 1.

HIV Vaccine Trials
Slide 1.

HIV Vaccine Trials
Slide 1.

Ad Campaign: HIV Vaccine Trials Unit
Slide 1.

Ad Campaign: SFisReady.org
Slide 1.

Ad Campaign: SFisReady.org
Slide 1.

Ad Campaign: SFisReady.org
Slide 1.

Ad Campaign: SFisReady.org
Slide 1.

Ad Campaign: SFisReady.org
Slide 1.

Ad Campaign: SFisReady.org
Slide 1.

Ad Campaign: project-embrace.org
Slide 1.

Ad Campaign: HelpFightHIV.org
Slide 1.

How You Can Help
Slide 1.

About | Site Map | Feedback | Subscribe | Donate | Disclaimer

UCSF - Center for HIV Information HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2013, Regents of the University of California.